nrg

NRG And Curium Sign Contract For Production of Mo-99

NRG And Curium Sign Contract For Production of Mo-99 NRG (ENS Corporate Member) and Curium have signed a multi-year contract for the production of molybdenum-99, the starting material for technetium-99m (Tc-99m). Tc-99m is the most used isotope in nuclear medicine for diagnosing life-threatening diseases, such as cardiovascular diseases, lung and brain disorders and cancer. With…

NCBJ JAEA

NCBJ And JAEA To Boost Research And Development In HTGRs

NCBJ And JAEA To Boost Research And Development In HTGRs On November 22, in Tokyo, the President of the Japanese Atomic Energy Agency (JAEA), Mr. Koguchi Masanori and the Director of the Polish National Centre for Nuclear Research (NCBJ), Prof. Krzysztof Kurek signed an Implementing Arrangement regarding the institution’s cooperation in research and development in…

NRG Tractebel

NRG And Tractebel To Support New NPPs In The Netherlands

NRG And Tractebel To Support New NPPs In The Netherlands On Friday, 17th March, NRG|PALLAS and Tractebel (both ENS Corporate Members) signed a Memorandum of Understanding to cooperate to support the new-build of nuclear power plants in the Netherlands. Bertholt Leeftink, CEO NRG|PALLAS, said Cooperation is a key element in realising such an ambitious project.…

NRG - Terbium-161

NRG And TerThera Cooperate To Secure Terbium-161 Supply

NRG And TerThera Cooperate To Secure Terbium-161 Supply Last week, NRG (ENS Corporate Member) and TerThera signed an agreement for irradiation services in the High Flux Reactor in Petten to produce Terbium-161. The non-carrier-added (NCA) Terbium-161 is produced by neutron irradiation of highly enriched Gadolinium-160 targets in the Dutch research reactor. Terbium-161 is a promising novel…

nuclear medicine cooperation

NRG|PALLAS and Curium Expand Cooperation in Lu-177 Production

NRG|PALLAS and Curium Expand Cooperation in Lu-177 Production NRGIPALLAS (ENS Corporate Member) and Curium have signed a long-term agreement to expand the current cooperation to include the production of lutetium-177 (Lu-177). This agreement will enable Curium to supply about 70,000 doses of Lu-177 annually, which will help about 14,000 patients per year. Curium and NRG…